Hypoxanthine transport through the blood-brain barrier
- PMID: 3670521
- DOI: 10.1007/BF00971517
Hypoxanthine transport through the blood-brain barrier
Abstract
The unidirectional influx of hypoxanthine across cerebral capillaries, the anatomical locus of the blood-brain barrier, was measured with an in situ rat brain perfusion technique employing [3H]hypoxanthine. Hypoxanthine was transported across the blood-brain barrier by a saturable system with a one-half saturation concentration of approximately 0.4 mM. The permeability-surface area product was 3 X 10(-4) sec-1 with a hypoxanthine concentration of 0.02 microM in the perfusate. Adenine (4 mM) and uracil and theophylline (both 10 mM), but not inosine (10 mM) or leucine (1 mM), inhibited hypoxanthine transfer through the blood-brain barrier. Thus, hypoxanthine is transported through the blood-brain barrier by a high-capacity, saturable transport system with a half-saturation concentration about 100 times the plasma hypoxanthine concentration. Although involved in the transport hypoxanthine from blood into brain, this system is not powerful enough to transfer important quantities of hypoxanthine from blood into brain.
Similar articles
-
Pantothenic acid transport through the blood-brain barrier.J Neurochem. 1986 Sep;47(3):966-71. doi: 10.1111/j.1471-4159.1986.tb00705.x. J Neurochem. 1986. PMID: 3734807
-
Biotin transport through the blood-brain barrier.J Neurochem. 1987 Feb;48(2):400-4. doi: 10.1111/j.1471-4159.1987.tb04107.x. J Neurochem. 1987. PMID: 3098919
-
Transport of amantadine and rimantadine through the blood-brain barrier.J Pharmacol Exp Ther. 1988 Feb;244(2):516-9. J Pharmacol Exp Ther. 1988. PMID: 3346834
-
Myo-inositol transport through the blood-brain barrier.Neurochem Res. 1988 Aug;13(8):785-7. doi: 10.1007/BF00971603. Neurochem Res. 1988. PMID: 3173626
-
Indicator dilution estimation of capillary endothelial transport.Annu Rev Physiol. 1986;48:321-34. doi: 10.1146/annurev.ph.48.030186.001541. Annu Rev Physiol. 1986. PMID: 3518617 Free PMC article. Review.
Cited by
-
The Role of Purine Metabolism and Uric Acid in Postnatal Neurologic Development.Molecules. 2025 Feb 11;30(4):839. doi: 10.3390/molecules30040839. Molecules. 2025. PMID: 40005150 Free PMC article. Review.
-
Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine.Medicine (Baltimore). 2020 Aug 28;99(35):e21576. doi: 10.1097/MD.0000000000021576. Medicine (Baltimore). 2020. PMID: 32871874 Free PMC article. Clinical Trial.
-
Lumbricus Extract Prevents LPS-Induced Inflammatory Activation of BV2 Microglia and Glutamate-Induced Hippocampal HT22 Cell Death by Suppressing MAPK/NF-κB/NLRP3 Signaling and Oxidative Stress.Curr Issues Mol Biol. 2023 Dec 11;45(12):9926-9942. doi: 10.3390/cimb45120620. Curr Issues Mol Biol. 2023. PMID: 38132466 Free PMC article.
-
Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine models.Sci Rep. 2018 Oct 18;8(1):15458. doi: 10.1038/s41598-018-33453-4. Sci Rep. 2018. PMID: 30337562 Free PMC article.
-
Comprehensive blood metabolomics profiling of Parkinson's disease reveals coordinated alterations in xanthine metabolism.NPJ Parkinsons Dis. 2024 Mar 19;10(1):68. doi: 10.1038/s41531-024-00671-9. NPJ Parkinsons Dis. 2024. PMID: 38503737 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources